Loading stock data…
Addus HomeCare Corporation (ADUS)
$96.95+0.09 (+0.09%)
Market ClosedLast close Jun 26
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Addus HomeCare Corporation in the Healthcare sector is trading at $96.94 with a market capitalization of $1.8B. Wall Street consensus targets $132.69 (13 analysts), implying a +36.9% move over the next 12 months. The stock is currently 22% below its 52-week high of $124.44, remaining 8.3% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 84 is overbought against a weak tape. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +36.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 84 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $363.61M↓ | $373.08M↑ | $362.30M↑ | $349.44M↑ | $337.71M |
| Gross Profit | $115.87M↓ | $123.61M↑ | $116.72M↑ | $113.88M↑ | $107.68M |
| Operating Income | $34.07M↓ | $42.28M↑ | $32.94M↑ | $32.89M↑ | $30.51M |
| Net Income | $25.07M↓ | $29.78M↑ | $22.85M↑ | $22.05M↑ | $21.23M |
Peer Comparison
JNJUNHPFE
Fundamentals
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company op...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.79B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.94%
Volume
Today's trading volume
813,763
Recent News
3 of Wall Street’s Favorite Stocks That Fall Short
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
3 Healthcare Stocks with Open Questions
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 6.4% over the past six months, almost identical to the S&P 500.
1 Value Stock Worth Your Attention and 2 Facing Challenges
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Assessing Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness
Why Addus HomeCare Stock Is Back on Investors’ Radar Addus HomeCare (ADUS) has drawn fresh attention after a year in which the stock declined about 17% and is down about 13% year to date, despite reported revenue and net income growth. See our latest analysis for Addus HomeCare. The recent share price, at US$92.65, reflects a 90 day share price return that is down 11.93%, while the 3 year total shareholder return of 4.32% contrasts with a 1 year total shareholder return that is down 17.39%...
BrightSpring Leans Into Home Care as IRA Pricing Resets Hit
BTSG is navigating ~$600M of 2026 revenue headwinds while leaning on national scale and home-based coordination to drive margin expansion.